F. Princen

P. Rutgeerts, S. Vermeire, A. Gils, 2015, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Anti-TNF Therapeutic Drug Monitoring in Postoperative Crohn’s Disease

Steven J Brown, M. Kamm, W. Selby, 2018, Journal of Crohn's & colitis.

1029 Serological and Inflammatory IBD Marker Prevalence As Function of Age in a Large Cohort of Patients Presenting IBD-Like Gastrointestinal Symptoms

S. Plevy, Sharat Singh, F. Princen, 2013 .

Sa1818 – Innate Immune Dysregulation, Detectable Up to 6 Years Before the Diagnosis of Crohn's Disease, is Significantly Amplified in Patients with a Complicated Phenotype

J. Murray, Xiao-Jun Li, S. Plevy, 2019, Gastroenterology.

78 Longitudinal Status of Serological Markers Predict Crohn's Disease Phenotype Before Diagnosis: A ‘PREDICTS’ Study

J. Murray, R. Choung, J. Colombel, 2015 .

Serum Biomarkers Identify Patients Who Will Develop Inflammatory Bowel Diseases Up to 5 y Before Diagnosis.

J. Murray, Xiao-Jun Li, S. Plevy, 2020, Gastroenterology.

Rat gap junction connexin-30 inhibits proliferation of glioma cell lines.

D. Gros, M. Merville, V. Bours, 2001, Carcinogenesis.

Pharmacological modulation of the bystander effect in the herpes simplex virus thymidine kinase/ganciclovir gene therapy system: effects of dibutyryl adenosine 3',5'-cyclic monophosphate, alpha-glycyrrhetinic acid, and cytosine arabinoside.

G. Moonen, M. Merville, V. Bours, 2000, Biochemical pharmacology.

Ptpn11/Shp2 acts as a tumor suppressor in hepatocellular carcinogenesis.

T. Han, Hongyang Wang, V. Poli, 2011, Cancer cell.

Combined suicide and cytokine gene therapy for peritoneal carcinomatosis

P. Delvenne, M. Merville, V. Bours, 2000, Gut.

Cytosine deaminase suicide gene therapy for peritoneal carcinomatosis

M. Merville, V. Bours, A. Hellin, 2000, Cancer Gene Therapy.

Repeated cycles of retrovirus-mediated HSVtk gene transfer plus ganciclovir increase survival of rats with peritoneal carcinomatosis

M. Merville, V. Bours, J. Gielen, 1998, Gene Therapy.

HSV-1 thymidine kinase gene therapy for peritoneal carcinomatosis.

M. Merville, V. Bours, J. Gielen, 1998, Advances in experimental medicine and biology.

HSV-1 thymidine kinase gene therapy for colorectal adenocarcinoma-derived peritoneal carcinomatosis

M. Merville, V. Bours, J. Gielen, 1997, Gene Therapy.

Serologic microbial associated markers can predict Crohn's disease behaviour years before disease diagnosis

J. Murray, R. Choung, J. Colombel, 2016, Alimentary pharmacology & therapeutics.

Combined Serological, Genetic, and Inflammatory Markers Differentiate Non-IBD, Crohn's Disease, and Ulcerative Colitis Patients

L. Croner, M. Silverberg, S. Plevy, 2013, Inflammatory bowel diseases.

Modulation of the HSV-TK/ganciclovir bystander effect by n-butyrate in glioblastoma: correlation with gap-junction intercellular communication.

M. Merville, V. Bours, B. Malgrange, 2004, International journal of oncology.

Seventeen copies of the human 37 kDa laminin receptor precursor/p40 ribosome-associated protein gene are processed pseudogenes arisen from retropositional events.

V. Castronovo, P. Jackers, U. Wewer, 1996, Biochimica et biophysica acta.

IκB-α Enhances Transactivation by the HOXB7 Homeodomain-containing Protein*

M. Merville, V. Bours, J. Gielen, 1999, The Journal of Biological Chemistry.

Activated cMET and IGF1R-Driven PI3K Signaling Predicts Poor Survival in Colorectal Cancers Independent of KRAS Mutational Status

Joon-Oh Park, H. Kim, Anne Kuller, 2014, PloS one.

Role of Gab2 in mammary tumorigenesis and metastasis

G. Feng, W. Muller, G. Feng, 2007, Oncogene.

Performance Characteristics of a Clinical Decision Support Tool for Disease Complications in Crohn’s Disease

S. Targan, M. Dubinsky, D. McGovern, 2021, Crohn's & colitis 360.

A Matrix-based Model Predicts Primary Response to Infliximab in Crohn's Disease.

S. Vermeire, I. Cleynen, M. Ferrante, 2015, Journal of Crohn's & colitis.

Combination of genetic and quantitative serological immune markers are associated with complicated Crohn's disease behavior

M. Silverberg, S. Targan, M. Dubinsky, 2011, Inflammatory bowel diseases.

Cohort profile of the PRoteomic Evaluation and Discovery in an IBD Cohort of Tri-service Subjects (PREDICTS) study: Rationale, organization, design, and baseline characteristics

J. Murray, S. Telesco, R. Choung, 2019, Contemporary clinical trials communications.

Anti-microbial antibody response is associated with future onset of Crohn's disease independent of biomarkers of altered gut barrier function, subclinical inflammation, and genetic risk.

A. Paterson, P. Moayyedi, M. Silverberg, 2021, Gastroenterology.

Evolution of cytokines and inflammatory biomarkers during infliximab induction therapy and the impact of inflammatory burden on primary response in patients with Crohn’s disease

S. Vermeire, I. Cleynen, A. Gils, 2017, Scandinavian journal of gastroenterology.

999 Classification of non-IBD, Crohn's Disease and Ulcerative Colitis in a Young Patient Population Using a Multi-Marker Diagnostic Panel

Sharat Singh, F. Princen, S. Lockton, 2014 .

Pre-operative serological markers may predict postoperative Crohn's Disease recurrence

S. Vermeire, M. Ferrante, G. Assche, 2014 .

Preclinical Serological Signatures are Associated with Complicated Crohn's Disease Phenotype at Diagnosis.

J. Murray, S. Plevy, F. Petralia, 2023, Clinical Gastroenterology and Hepatology.

Tryptophan Hydroxlase 1 (TPH1) Promoter Genotype but not Serum Serotonin Levels Identify IBS-D Patients More Likely to Benefit from the Low Fodmap Diet

W. Chey, J. Merchant, Amanda L. Photenhauer, 2017 .

A Novel 8-Predictors Signature to Predict Complicated Disease Course in Pediatric-onset Crohn's Disease: A Population-based Study.

J. Hugot, F. Vasseur, G. Savoye, 2023, Inflammatory bowel diseases.

Serologic antibodies in relation to outcome in postoperative Crohn's disease

Steven J Brown, M. Kamm, W. Selby, 2017, Journal of gastroenterology and hepatology.

Serologic microbial associated markers can predict Crohn's disease behaviour years before disease diagnosis

J. Murray, R. Choung, J. Colombel, 2016, Alimentary pharmacology & therapeutics.